MOLECULAR BIOLOGY OF INFLUENZA VIRUSES Genome Organization Influenza virus types

M. Shaw,H. Arden,H. F. Maassab

Abstract:INTRODUCTION AND HISTORICAL BACKGROUND ................................................................74 MOLECULAR BIOLOGY OF INFLUENZA VIRUSES..................................................................75 Genome Organization .................................................................. 75 Transcription and Replication .................................................................. 75 Viral Glycoproteins .................................................................. 77 HA ................................................................. 77 NA ................................................................. 78 NB .................................................................. 78 Nonglycosylated Viral Proteins .................................................................. 78 P proteins .................................................................. 78 NP.................................................................. 78 Viral membrane proteins MI and M2 .................................................................. 79 NS proteins NS1 and NS2.................................................................. 79 EVOLUTION AND VARIATION .................................................................. 80 IMMUNOLOGIC DETERMINANTS IN INFLUENZA VIRUS INFECTION ......................................81 DIAGNOSIS .................................................................. 83 Differential Diagnosis.................................................................. 83 Laboratory Diagnosis .................................................................. 83 Serodiagnosis .................................................................. 83 PREVENTION AND CONTROL .................................................................. 84 Antiviral Agents .................................................................. 84 Amantadine and rimantadine .................................................................. 84 Ribavirin .................................................................. 84 Vaccines .................................................................. 84 Inactivated virus vaccines .................................................................. 84 Live attenuated virus vaccines ................................................................. 84 (i) Host range variant virus vaccines .................................................................. 85 (ii) Cold-adapted influenza virus vaccines.................................................................. 85 (iii) The 6/2 ca live virus vaccine line .................................................................. 86 (iv) Development of vaccines from live influenza virus type B ca reassortants .............................86 FUTURE PROSPECTS.................................................................. 86 REFERENCES .................................................................. 87